Cirtran Corp CIRX OTC · Consumer defensive · United States
$0.02 -13.17% -$0.00
Summary
55 / 100 · Bulios Score
What speaks for it
- Out of every 100 USD of revenue, 44 USD is left as net profit.
- Revenue grew by 22% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
What to watch
- Operating profit does not even cover the interest on its debt.
- It reports a profit, yet spends more cash than it brings in.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 0.0 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
Revenue grew by 13% a year over 5 years. Over the last 3 years it grew by 22% a year.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 53 USD
- Sales and administration 41 USD
- Taxes and other -38 USD
- Net profit 44 USD
Net profit, industry median (Food Distribution) 2.2 USD
Out of every 100 USD of revenue, 44 USD is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenOver the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
Fiscal year 2023By product
- Product Delivery to Customers 75%
- Product Development Service 25%
By region
- United States 50%
- South America 27%
- Segment Geographical Groups Of Countries Group Four 12%
- Segment Geographical Groups Of Other Countries Group 6.1%
- Canada 5.3%
Product Delivery to Customers brings in 75% of revenue.
Segments in detail